Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Construction in Progress: 2019-2020

  • Legend Biotech's Construction in Progress rose 1082.74% to $33.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $33.6 million, marking a year-over-year increase of 1082.74%. This contributed to the annual value of $33.6 million for FY2020, which is 1082.74% up from last year.
  • Per Legend Biotech's latest filing, its Construction in Progress stood at $33.6 million for Q4 2020, which was up 1,082.74% from $2.8 million recorded in Q4 2019.
  • Legend Biotech's Construction in Progress' 5-year high stood at $33.6 million during Q4 2020, with a 5-year trough of $2.8 million in Q4 2019.
  • Moreover, its 2-year median value for Construction in Progress was $18.2 million (2019), whereas its average is $18.2 million.
  • Data for Legend Biotech's Construction in Progress shows a peak YoY surged of 1,082.74% (in 2020) over the last 5 years.
  • Over the past 2 years, Legend Biotech's Construction in Progress (Quarterly) stood at $2.8 million in 2019, then spiked by 1,082.74% to $33.6 million in 2020.